Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maternus-Kliniken AGXTER:MAK +3.26%45 EV-to-OCF is 14.10 as of Aug. 30, 2026, which is 3% below its 10-year median of 14.54. GuruFocus rates XTER:MAK with a GF Score™ of 45/100 and a GF Value™ of €1.87 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Maternus-Kliniken AG ranks worse than 66.57% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Maternus-Kliniken AG's Enterprise Value is €197.8 Mil.
Maternus-Kliniken AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €14.0 Mil. Therefore, Maternus-Kliniken AG's EV-to-OCF for today is 14.10.
The historical rank and industry rank for Maternus-Kliniken AG's EV-to-OCF or its related term are showing as below:
XTER:MAK'
s EV-to-OCF Range Over the Past 10 Years
Min: -38.44 Med: 14.54 Max: 85.31
Current: 14.1
During the past 13 years, the highest EV-to-OCF of Maternus-Kliniken AG was 85.31. The lowest was -38.44. And the median was 14.54.
XTER:MAK's EV-to-OCF is ranked worse than 66.57% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 9.12
vs XTER:MAK: 14.10
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Maternus-Kliniken AG (XTER:MAK) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Maternus-Kliniken AG's PE Ratio (TTM) for today is calculated as:
Maternus-Kliniken AG's share price for today is €0.95.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maternus-Kliniken AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.660.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Maternus-Kliniken AG EV-to-OCF Related Terms
Maternus-Kliniken AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Maternus-Kliniken AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Maternus-Kliniken AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maternus-Kliniken AG EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maternus-Kliniken AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Maternus-Kliniken AG's EV-to-OCF falls into.
Maternus-Kliniken AG's current Enterprise Value is €197.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maternus-Kliniken AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €14.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maternus-Kliniken AG (XTER:MAK) has a EV-to-OCF of 14.10 as of Aug. 30, 2026. This is near median its historical median of 14.54. According to the industry distribution chart, Maternus-Kliniken AG ranks #456 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 66.6%.
Is Maternus-Kliniken AG's EV-to-OCF too high?
Maternus-Kliniken AG's current EV-to-OCF of 14.10 is near median its 10-year median of 14.54. The Healthcare Providers & Services industry median EV-to-OCF is 9.12. Maternus-Kliniken AG's value of 14.10 is 54.6% above this industry median. Based on the distribution chart, Maternus-Kliniken AG ranks #456 out of 685 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Maternus-Kliniken AG has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maternus-Kliniken AG's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Maternus-Kliniken AG ranks #456 out of 685 companies for EV-to-OCF. This places Maternus-Kliniken AG in the lower half of its industry. The industry median EV-to-OCF is 9.12. Maternus-Kliniken AG's value of 14.10 is 54.6% above this benchmark. While the company's 10-year median is 14.54 vs. the industry median of 9.12, Maternus-Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 9.12, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maternus-Kliniken AG's current EV-to-OCF of 14.10 is 54.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 9.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maternus-Kliniken AG's current EV-to-OCF is 14.10, which is near median its own 10-year median of 14.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maternus-Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, Maternus-Kliniken AG (XTER:MAK) is currently considered Possible Value Trap. The stock's GF Value™ is €1.87, compared to a current price of €0.95 — trading 49.2% below its estimated fair value. The current EV-to-OCF is 14.10, which is near median its 10-year median of 14.54 and 54.6% above the Healthcare Providers & Services industry median of 9.12. Maternus-Kliniken AG's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Maternus-Kliniken AG (XTER:MAK), the current EV-to-OCF is 14.10 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maternus-Kliniken AG (XTER:MAK) Overvalued in 2026?
Based on GuruFocus' analysis, Maternus-Kliniken AG stock appears to be undervalued.
The current stock price of €0.95 is trading 49.2% below its estimated GF Value™ of €1.87.
GuruFocus considers Maternus-Kliniken AG to be Possible Value Trap.
Key valuation signals for XTER:MAK:
EV-to-OCF: 14.10 (near median its 10-year median of 14.54)
GF Value™: €1.87 vs. price of €0.95 (49.2% below fair value)
Industry Position: 54.6% above the Healthcare Providers & Services median (#456 of 685)
No single metric tells the full story. See the XTER:MAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:MAK has been successfully added to your 
